trending Market Intelligence /marketintelligence/en/news-insights/trending/V2kwkLWIVSFkRzgRjfYLgw2 content esgSubNav
In This List

Diagnos seeks to restructure its debt, implement 1-for-10 reverse stock split

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


Diagnos seeks to restructure its debt, implement 1-for-10 reverse stock split

Diagnos Inc. plans to reorganize its debt and capital structure and has proposed an amendment to its 10% secured convertible debentures along with a 1-for-10 reverse stock split.

Under the proposed amendment, Diagnos will offer holders of its 10% secured convertible debentures about C$4.9 million in common shares at 3.5 Canadian cents apiece.

The company will seek approval for the amendment from the holders of the debentures in a meeting scheduled for April 4. After gaining their approval, the company plans to seek further conversion of debentures worth C$1 million into common shares at the same price.

The Brossard, Quebec-based ophthalmological diagnostics company will conduct a special meeting with its shareholders April 10 to seek their approval for the share consolidation.

The amendment, repayment and conversion of debentures are subject to approval from TSX Venture Exchange and can only be completed after the company gets shareholder approval for the reverse stock split to meet the exchange's requirement of 5 cents minimum share issuance price.